Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 32 Pain, Postoperative 18 Neoplasms 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Lung Neoplasms 12 Brain Neoplasms 12 Prostatic Neoplasms 9 Ovarian Neoplasms 9 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Stomach Neoplasms 7 Depression 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Pain 6 Head and Neck Neoplasms 6 Thyroid Neoplasms 5 Pancreatic Neoplasms 5 Multiple Myeloma 5 Leiomyoma 5 Agnosia 5 Neoplasm Metastasis 4 Lymphoma 4 Fatigue 4 Delirium 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3

Interventions

Cisplatin 8 Carboplatin 8 Bevacizumab 8 Pleurodesis 7 Talc 6 Paclitaxel 6 Docetaxel 5 Povidone-Iodine 4 Doxycycline 4 Thoracoscopy 3 Taxes 3 Gemcitabine 3 Drug Therapy 3 Chest Tubes 3 aldesleukin 2 Zoledronic Acid 2 Trastuzumab 2 Thoracentesis 2 Surveys and Questionnaires 2 Sodium Chloride 2 Silver Nitrate 2 Pharmaceutical Preparations 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 High-Energy Shock Waves 2 Fluorodeoxyglucose F18 2 Fentanyl 2 Erlotinib Hydrochloride 2 Cetuximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Effusion, Malignant × Saline Solution × Clear all

NCT01411202 2020-09-25

OPUS

Ottawa Hospital Research Institute

Phase 2 Unknown

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡